![David Bleakman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Bleakman
Direttore Tecnico/Scientifico/R&S presso Redpin Therapeutics, Inc.
Profilo
David Bleakman has worked as a Chief Scientific Officer at Redpin Therapeutics, Inc. since 2018.
Posizioni attive di David Bleakman
Società | Posizione | Inizio |
---|---|---|
Redpin Therapeutics, Inc.
![]() Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Redpin Therapeutics, Inc. operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders. The company was founded by Elma S. Hawkins, Jeffrey Friedman, Scott Sternson Michael Kaplitt, Sarah Stanley and Jonathan Dordick in 2017 and is headquartered in New York, NY. | Direttore Tecnico/Scientifico/R&S | 15/10/2018 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Redpin Therapeutics, Inc.
![]() Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Redpin Therapeutics, Inc. operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders. The company was founded by Elma S. Hawkins, Jeffrey Friedman, Scott Sternson Michael Kaplitt, Sarah Stanley and Jonathan Dordick in 2017 and is headquartered in New York, NY. | Commercial Services |
- Borsa valori
- Insiders
- David Bleakman